CTSH Stock Analysis — AI Buy/Sell Signals & Forecast
Real-time AI-powered analysis for CTSH with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
CTSH · Cognizant Technology Solutions Corporation
Free summary — full analysis below.
Cognizant Technology Solutions Corporation
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 8, 07:11 AM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Strong Downtrend — Price below SMA50 & SMA200, Death Cross
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-29.96 (-34.4%) from high
Day's Range: $56.38 – $57.90
+$19.99 (+53.9%) above low
▼ Below — short-term downtrend (bearish)
▼ Below — long-term downtrend (bearish)
✓ 0.8x avg — normal activity, signals are reliable
✓ Normal — healthy trading conditions
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
Cognizant's strategic five-year partnership extension with Gilead Sciences highlights strong recurring revenue and deep integration into critical DevOps and AI initiatives. This long-term contract solidifies their market position and provides a stable foundation for sustained growth in enterprise technology services.
Latest News & Market Impact
What Is Accenture Building That Investors Should Watch?
Gilead Sciences signs five-year DevOps agreement with Cognizant
Gilead Sciences signs five-year DevOps agreement with Cognizant
Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
CTSH Stock Analysis — Frequently Asked Questions
Is CTSH a buy or sell right now?▾
Our AI engine analyzes CTSH across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
What is the price target for CTSH?▾
The analysis calculates optimal entry and exit price targets for CTSH using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
What do the RSI and MACD signals say about CTSH?▾
RSI measures whether CTSH is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
Are institutions buying CTSH?▾
We track institutional positioning in CTSH through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
What are the main risks of investing in CTSH?▾
Key risks for CTSH include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
How accurate is the CTSH AI analysis?▾
The CTSH analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.